An inhibitor of uric acid reabsorption
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Sulfinpyrazone

Item No. 17847

Technical Information
Formal Name
1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]-3,5-pyrazolidinedione
CAS Number
57-96-5
Synonyms
  • G-28315
  • NSC 75925
Molecular Formula
C23H20N2O3S
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 30 mg/mlDMSO: 30 mg/mlDMSO:PBS(pH7.2) (1:1): 0.5 mg/mlEthanol: 1 mg/ml
λmax
245 nm
SMILES
O=C(N(C1=CC=CC=C1)N2C3=CC=CC=C3)C(CCS(C4=CC=CC=C4)=O)C2=O
InChi Code
InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2
InChi Key
MBGGBVCUIVRRBF-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Sulfinpyrazone is a uricosuric agent that competitively inhibits uric acid (Item No. 16219) reabsorption in kidney proximal tubules, which is a key mechanism targeted in the treatment of gout.1,2 It can also inhibit degranulation of platelets, reducing the release of ADP and thromboxane and diminishing platelet aggregation.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Montgomery, D.B., and Ogryzlo, M.A. Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin). Can. Med. Assoc. J. 83, 885-888 (1960).

    2. Underwood, M. Diagnosis and management of gout. BMJ 332, 1315-1319 (2006).

    3. Pedersen, A.K., and Jakobsen, P. Sulphinpyrazone metabolism during long-term therapy. Br. J. Clin. Pharmac. 11(6), 597-603 (1981).

    Product Citations

    Rana, P.S., Gibbons, B.A., Vereninov, A.A., et alCalibration and characterization of intracellular Asante Potassium Green probes, APG-2 and APG-4. Anal. Biochem. 567, 8-13 (2019).